| Literature DB >> 23077595 |
Sabina Dongol1, Corinne N Thompson, Simon Clare, Tran Vu Thieu Nga, Pham Thanh Duy, Abhilasha Karkey, Amit Arjyal, Samir Koirala, Nely Shrestha Khatri, Pukar Maskey, Sanjay Poudel, Vijay Kumar Jaiswal, Sujan Vaidya, Gordon Dougan, Jeremy J Farrar, Christiane Dolecek, Buddha Basnyat, Stephen Baker.
Abstract
Gallbladder carriage of invasive Salmonella is considered fundamental in sustaining typhoid fever transmission. Bile and tissue was obtained from 1,377 individuals undergoing cholecystectomy in Kathmandu to investigate the prevalence, characteristics and relevance of invasive Salmonella in the gallbladder in an endemic area. Twenty percent of bile samples contained a Gram-negative organism, with Salmonella Typhi and Salmonella Paratyphi A isolated from 24 and 22 individuals, respectively. Gallbladders that contained Salmonella were more likely to show evidence of acute inflammation with extensive neutrophil infiltrate than those without Salmonella, corresponding with higher neutrophil and lower lymphocyte counts in the blood of Salmonella positive individuals. Antimicrobial resistance in the invasive Salmonella isolates was limited, indicating that gallbladder colonization is unlikely to be driven by antimicrobial resistance. The overall role of invasive Salmonella carriage in the gallbladder is not understood; here we show that 3.5% of individuals undergoing cholecystectomy in this setting have a high concentration of antimicrobial sensitive, invasive Salmonella in their bile. We predict that such individuals will become increasingly important if current transmission mechanisms are disturbed; prospectively identifying these individuals is, therefore, paramount for rapid local and regional elimination.Entities:
Mesh:
Year: 2012 PMID: 23077595 PMCID: PMC3471863 DOI: 10.1371/journal.pone.0047342
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Antimicrobial resistance patterns of Gram-negative organisms from the bile of patients undergoing cholecystectomy.
| Organism | Patients | Antimicrobial resistance n (%) | ||||||||
| n (%) | Amoxicillin | Cefotaxime | Ciprofloxacin | Ofloxacin | Chloramphenicol | Cotrimoxazole | Gentamycin | Amikacin | Nalidixic Acid | |
| Typhi | 24 (1.7) | 0/23 (0) | 0/24 (0) | 0/24 (0) | 0/24 (0) | 0/22 (0) | 4/23 (17.4) | 0/11 (0) | 0/0 (0) | 11/22 (50.0) |
| Paratyphi A | 22 (1.6) | 0/22 (0) | 0/22 (0) | 1/22 (4.5) | 1/22 (4.5) | 2/22 (9.1) | 0/22 (0) | 0/16 (0) | 0/1 (0) | 16/19 (84.2) |
| Other | 2 (0.1) | 1/2 (50.0) | 0/2 (0) | 0/2 (0) | 0/2 (0) | 1/2 (50) | 0/2 (0) | 0/1 (0) | 0/0 (0) | 1/2 (50.0) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| 78 (5.7) | 32/76 (42.1) | 12/76 (15.8) | 23/77 (29.9) | 21/77 (27.3) | 14/69 (20.3) | 22/76 (28.9) | 4/40 (10.0) | 0/39 (0) | 20/42 (47.6) |
|
| 41 (3.0) | 36/39 (92.3) | 9/39 (23.1) | 6/39 (15.4) | 6/38 (15.8) | 12/38 (31.6) | 11/39 (28.2) | 4/24 (16.7) | 1/25 (4.0) | 9/18 (50.0) |
|
| 33 (2.4) | 23/31 (74.2) | 4/31 (12.9) | 4/31 (12.9) | 4/31 (12.9) | 21/28 (75.0) | 21/30 (70.0) | 2/20 (10.0) | 1/18 (5.6) | 9/13 (69.2) |
|
| 19 (1.4) | 14/19 (73.7) | 7/19 (36.8) | 6/19 (31.6) | 4/19 (21.1) | 11/19 (57.9) | 9/19 (47.4) | 5/9 (55.6) | 4/10 (40.0) | 6/11 (54.5) |
|
| 21 (1.5) | 16/19 (84.2) | 6/20 (30.0) | 2/20 (10.0) | 1/20 (5.0) | 3/19 (15.8) | 3/20 (15.0) | 1/8 (12.5) | 0/5 (0) | 2/14 (14.3) |
| Other | 34 (2.5) | 14/18 (77.8) | 5/20 (25.0) | 3/20 (15.0) | 2/17 (11.8) | 5/18 (27.8) | 3/18 (16.7) | 1/4 (25.0) | 1/3 (33.3) | 5/19 (26.3) |
|
|
|
|
|
|
|
|
|
|
|
|
The baseline characteristics of the Salmonella positive, culture negative and the culture positive for non-Salmonella bile culture groups.
| Women | Men | Typhoid fever history | Surgery | ||||||
| Culture group | Patients | Age | Patients | Age | Patients | Clinical diagnosis | Culture diagnosis | Elective | Acute |
| n (%) | Median (range) | n (%) | Median (range) | n (%) | n (%) | n (%) | n (%) | n (%) | |
|
| 48 (3.5) | 34.5 (20–67) | 35 (72.9) | 38 (18–57) | 13 (27.1) | 7 (14.6) | 0 (0) | 33 (68.8) | 10 (20.8) |
| Culture positive for non- | 226 (16.4) | 39 (16–76) | 167 (73.9) | 46 (11–80) | 50 (22.1) | 35 (15.5) | 12 (5.3) | 200 (88.5) | 10 (4.4) |
| Culture negative | 1103 (80.1) | 38 (16–76) | 864 (78.3) | 44 (11–75) | 214 (19.4) | 176 (16.0) | 29 (2.6) | 983 (89.1) | 61 (5.5) |
| Total | 1377 (100) | 39 (16–76) | 1066 (77.4) | 45 (11–80) | 277 (20.1) | 218 (15.8) | 41 (3.0) | 1216 (88.3) | 81 (5.9) |
The haematological and the biochemical characteristics of the Salmonella positive, culture negative and the culture positive for non-Salmonella bile culture groups.
| Hematology | Culture negative | Culture positive non- |
| p1 | p2 | ||||||
| n | median | IQR | n | median | IQR | n | median | IQR | |||
| Total cell (×103/µL) | 953 | 7.9 | 6.6–9.5 | 188 | 7.85 | 6.45–10.15 | 42 | 9.45 | 6.4–14 |
| 0.058 |
| Neutrophil (×103/µL) | 917 | 66 | 58–74 | 177 | 65 | 58–75 | 41 | 72 | 60–82 |
|
|
| Lymphocyte (×103/µL) | 914 | 31 | 24–38 | 175 | 31 | 23–38 | 40 | 24.5 | 17–36 |
|
|
| Monocyte (×103/µL) | 270 | 1 | 1–2 | 70 | 1.5 | 1–2 | 9 | 1 | 1–2 | 0.676 | 0.848 |
| Eosinophil (×103/µL) | 641 | 2 | 1–4 | 131 | 2 | 1–4 | 22 | 2 | 2–4 | 0.999 | 0.515 |
| Basophil (×103/µL) | 54 | 0 | 0–1 | 14 | 0 | 0–0 | 1 | 6 | – | 0.058 |
|
| Total bilirubin (mg/mL) | 965 | 0.8 | 0.68–1 | 190 | 0.8 | 0.7–1 | 42 | 0.86 | 0.7–1.1 | 0.119 | 0.280 |
| Conjugated bilirubin (mg/mL) | 950 | 0.2 | 0.19–0.26 | 186 | 0.2 | 0.18–0.24 | 41 | 0.2 | 0.2–0.28 | 0.414 | 0.419 |
| AST (u/L) | 961 | 30 | 23–41 | 190 | 29.5 | 23–40 | 42 | 28 | 24–38.9 | 0.878 | 0.986 |
| ALT (u/L) | 960 | 30 | 21.9–43 | 188 | 29.5 | 21–43.5 | 42 | 30.5 | 24–41 | 0.898 | 0.953 |
| ALP (u/L) | 941 | 122 | 82–209 | 188 | 150.5 | 94.5–232.5 | 42 | 124.5 | 96–191 | 0.622 | 0.276 |
| Amylase (u/L) | 136 | 61.5 | 41.5–252.5 | 20 | 57.5 | 38–86.5 | 9 | 87 | 34–190 | 0.867 | 0.437 |
Mann-Whitney U test, boldface indicates p≤0.05.
p1: Comparing culture-negative to Salmonella-positive patients.
p2: Comparing culture positive for non-Salmonella to Salmonella-positive patients.
IQR: Interquartile range.
The gallbladder characteristics within the Salmonella positive, culture negative and the culture positive for non-Salmonella bile culture groups.
| Characteristic | Culture negative | Culture positive non- |
|
|
|
| n = 1,103 | n = 214 | n = 48 | |||
|
| |||||
| Thick (>4 mm) | 173 (15.7) | 36 (16.8) | 10 (20.8) | 0.350 | 0.602 |
| Normal (4 mm) | 493 (44.7) | 86 (40.0) | 21 (43.8) | ||
| Thin (<4 mm) | 74 (6.7) | 12 (5.6) | 1 (2.1) | ||
|
| |||||
| Contracted | 108 (9.8) | 25 (11.7) | 1 (2.1) |
|
|
| Distended | 221 (20.0) | 52 (24.3) | 15 (31.3) | ||
|
| |||||
| None | 19 (1.7) | 6 (2.8) | 3 (6.3) | 0.101 | 0.481 |
| Single | 344 (31.2) | 62 (29.0) | 14 (29.2) | ||
| Multiple | 684 (62.0) | 133 (62.1) | 28 (58.3) | ||
|
| |||||
| Inflammation | 93 (8.4) | 17 (7.9) | 8 (16.7) |
| 0.060 |
| Empyema | 90 (8.2) | 21 (9.8) | 10 (20.8) |
|
|
| Sludge | 57 (5.2) | 8 (3.7) | 1 (2.1) | 0.338 | 0.581 |
| Mucocele | 50 (4.5) | 7 (3.3) | 1 (2.1) | 0.427 | 0.664 |
Fisher’s exact test, boldface indicates p≤0.05.
p1: Comparing culture-negative to Salmonella-positive patients.
p2: Comparing culture-positive, Salmonella-negative to Salmonella-positive patients.